TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls
TRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls
Read moreTRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls
Read moreIN BRIEF: NetScientific's EMV advises on SageTech funding round
Read moreTRADING UPDATES: Beximco's India jab mire; Lamprell gets Aramco deal
Read moreTRADING UPDATES: Aquis maiden full-year profit; Tern turns to profit
Read moreIN BRIEF: NetScientific's vaccine consortium gains funding commitment
Read moreIN BRIEF: NetScientific Says Blanver Joins Covid Vaccine Consortium
Read moreNetScientific's ProAxsis Inks Licensing Deal With University Of Geneva
Read moreIN BRIEF: NetScientific Shares Restored After Drug Trial Announcement
Read moreIN BRIEF: NetScientific Shares Suspended Pending Notification
Read moreUK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain
Read moreIN BRIEF: NetScientific's ProAxisis Wins Innovate UK Grant For Project
Read more(Sharecast News) - Technology commercialisation company NetScientific announced on Thursday that its portfolio company ProAxsis has been awarded a high impact Innovate UK grant, as part of the recent 'UKRI Ideas to Address Covid-19' competition.
Read moreIN BRIEF: NetScientific Subsidiary Leads Financing Round In SageTech
Read moreIN BRIEF: NetScientific's ProAxsis Partners Up With DiaPharma
Read more(Sharecast News) - Life sciences, technology investment and commercialisation company NetScientific announced on Thursday that its portfolio company ProAxsis has appointed DiaPharma Group as the exclusive distributor of its portfolio of respiratory research assays for the key North America region.
Read more